Hadasit Bio-Holdings Ltd. is a publicly traded subsidiary (OTCBB: HADSY) of the Hadassah University Hospital, Israel's foremost medical research center, promoting medical breakthroughs. HadasitBio focuses on supporting its portfolio companies as they advance towards Phase II clinical trials and general assistance including pre-clinical trials, manufacturing, regulatory and business development tasks.
Looking for a particular Hadasit Bio-Holdings Ltd. employee's phone or email?
The Hadasit Bio-Holdings Ltd. annual revenue was $5.5 million in 2026.
Liat Simhayoff is the CFO of Hadasit Bio-Holdings Ltd..
3 people are employed at Hadasit Bio-Holdings Ltd..
The NAICS codes for Hadasit Bio-Holdings Ltd. are [541, 54171, 54, 62, 541711, 5417, 621, 6215, 62151].
The SIC codes for Hadasit Bio-Holdings Ltd. are [37, 372, 62, 621].